http://web.archive.org/web/20090129114244id_/http://www.cnn.com:80/2009/BUSINESS/01/25/pfizer.wyeth/index.html?eref=rss_latest

@entity0 -- @entity2 is near a deal to buy rival drugmaker @entity4 for $ 68 billion , according to news reports late sunday citing people familiar with the deal			1
@entity2 's world headquarters is in @entity0			2
a deal was imminent and likely to be announced monday , @entity10 and the @entity11 reported			0
" it is our policy not to comment on rumor or speculation , " said @entity13 , a @entity4 representative			1
@entity2 was not immediately available for comment			1
@entity2 , the world 's leading drugmaker in terms of sales , has been in talks to buy @entity4			1
@entity2 's stock slipped 1 percent on the news friday , while @entity4 gained about 8 percent			1
on january 13 @entity2 said it was cutting up to 8 percent of its r&d staff , about 800 jobs			1
spokesman @entity28 said that was to " raise productivity			0
" but analysts say @entity2 is clearly trying to beef up its drug pipeline through an acquisition , adding that the company seems to have given up on its own r&d staff coming up with a blockbuster to replace @entity37			1
this cholesterol - cutting drug peaked in 2006 with nearly $ 13 billion in annual sales but will lose its patent protection in 2011 , when generic versions will become available			0
@entity42 , pharma analyst for @entity43 , said @entity2 is " not feeling that they 're getting the efficiency out of their r&d unit			2
" he said @entity2 would probably rather do a deal with @entity4 over other competitors , because there is less overlap in the companies ' pipelines			1
@entity42 said @entity2 already has a diabetes franchise , which would overlap with @entity55 and @entity56 , both of which also focus on diabetes treatments			0
@entity2 probably has its eyes on @entity4 's @entity61 's drug pipeline , he said			2
but he cautions that a merger wo n't be a success unless @entity4 's pipeline is successful , which remains to be seen , he said			0
" if @entity4 comes out with an @entity61 's drug that works , then the deal works , " he said			0
@entity2 is probably also focused on @entity4 's blockbuster children 's vaccine @entity69 , as well as its experimental biotech drugs , said @entity71 of @entity72			2
sales of @entity69 , which combats meningitis and blood infections , jumped 12 percent in the first nine months of 2008 compared with the same period the prior year , to $ 2.1 billion			0
if a deal does go through , @entity42 warns , @entity4 staffers should brace for layoffs			0
" i can say with pretty good confidence that this is going to lead to some head count reduction , " he said .			0

" it is our policy not to comment on rumor or speculation , " @entity4 rep says
@entity2 was not immediately available for comment
@entity2 said this month it was cutting up to 8 percent , or 800 jobs , of its r&d staff

@entity2:Pfizer
@entity1:CNN
@entity0:New York
@entity13:Michael Lampe
@entity37:Lipitor
@entity11:New York Times
@entity10:The Wall Street Journal
@entity55:Eli Lilly & Co.
@entity28:Raymond Kerins
@entity4:Wyeth
@entity43:Miller Tabak
@entity56:Bristol-Myers Squibb
@entity42:Funtleyder
@entity69:Prevnar
@entity61:Alzheimer
@entity71:Michael Krensavage
@entity72:Krensavage Asset Management